Wang Junyu, Yuan Yuan, Xie Ting, Zhang Ligong, Xu Hong, Lin Shu-Cheng, Yang Yong, Zhu Dong, Zhuang Jie
Hunan University of Medicine, China; School of Exercise and Health, Shanghai University of Sport, China.
School of Physical Education, Kunsan National University, Republic of Korea.
J Sci Med Sport. 2025 Apr;28(4):282-291. doi: 10.1016/j.jsams.2025.01.003. Epub 2025 Jan 16.
This study aimed to evaluate the dose-response relationship between different exercise types and the alleviation of motor symptoms in Parkinson's Disease patients.
A systematic review and network meta-analysis were conducted to compare the effects of 12 exercise types on motor symptoms in Parkinson's Disease patients using randomized controlled trials.
A systematic search was conducted across PubMed, Medline, Embase, PsycINFO, Cochrane Library, and Web of Science until September 10, 2024. A total of 81 trials involving 4596 patients were included. Mean differences with 95 % credible intervals were calculated, and evidence quality was assessed using Confidence in Network Meta-Analysis. The Minimum Clinically Important Difference was used to assess clinical efficacy.
The optimal exercise dose for overall motor symptom improvement was 1300 MET-min/week (mean difference: -6.07, 95 % credible intervals: -8.10 to -4.01). Dance at 850 MET-min/week provided the greatest improvement (mean difference: -11.18, 95 % credible intervals: -16.01 to -6.22). Significant improvements were seen with doses as low as 60-100 MET-min/week for body weight support training, dance, resistance training, and sensory exercise. The Minimum Clinically Important Difference was achieved with doses exceeding 670 MET-min/week for overall exercise, and at lower doses for specific types: aerobic exercise (1100 MET-min/week), body weight support (420 MET-min/week), and dance (230 MET-min/week).
The optimal exercise dose for alleviating motor symptoms in Parkinson's Disease patients is 1300 MET-min/week, with dance being most effective at 850 MET-min/week. These findings provide evidence-based recommendations for Parkinson's Disease management.
本研究旨在评估不同运动类型与帕金森病患者运动症状缓解之间的剂量反应关系。
进行了一项系统评价和网络荟萃分析,以使用随机对照试验比较12种运动类型对帕金森病患者运动症状的影响。
在PubMed、Medline、Embase、PsycINFO、Cochrane图书馆和科学网进行了系统检索,直至2024年9月10日。共纳入81项试验,涉及4596名患者。计算了具有95%可信区间的平均差异,并使用网络荟萃分析的置信度评估证据质量。使用最小临床重要差异来评估临床疗效。
总体运动症状改善的最佳运动剂量为1300梅脱-分钟/周(平均差异:-6.07,95%可信区间:-8.10至-4.01)。每周850梅脱-分钟的舞蹈带来的改善最大(平均差异:-11.18,95%可信区间:-16.01至-6.22)。对于体重支持训练、舞蹈、阻力训练和感觉运动,每周低至60 - 100梅脱-分钟的剂量也能带来显著改善。总体运动剂量超过670梅脱-分钟/周可达到最小临床重要差异,而特定类型运动在较低剂量时即可达到:有氧运动(1100梅脱-分钟/周)、体重支持(420梅脱-分钟/周)和舞蹈(230梅脱-分钟/周)。
帕金森病患者缓解运动症状的最佳运动剂量为1300梅脱-分钟/周,舞蹈在每周850梅脱-分钟时最有效。这些发现为帕金森病的管理提供了基于证据的建议。